NN anchor Kaitlan Collins and legal analyst Elie Honig

New Post Public Reply Private Reply Replies (0) Message Board
dw
83
NN anchor Kaitlan Collins and legal analyst Elie Honig agreed that the appeals court denial against Mark Meadows is a “very bad signal” for ex-President Donald Trump’s claim of presidential immunity.

News broke Monday that the 11th Circuit Court of Appeals denied an attempt by Mark Meadows to move the Georgia election crimes case against him to federal court.

On Monday night’s edition of CNN’s The Source with Kaitlan Collins, the anchor and Honig argued this is a road map for the Supreme Court to torpedo Trump’s immunity claim:

COLLINS: I think it is a question of whether or not it’s a healing process. But, Elie, Jen makes an important point there that this is bigger than just Mark Meadows. What this could mean for Donald Trump and his immunity claims that we know he’s planning to make not just here, but in other prosecutions as well. And the signals that it is sending to someone like Justice Clarence Thomas, whom ideologically is pretty aligned with Judge Pryor here.

HOENIG: I think you said the exact right word, which is signals. Of course, what the 11th Circuit or any court of appeals or lower court does is not binding on the U.S. Supreme Court, they’re going to do what they’re going to do. But justices absolutely will look at opinions below and evaluate the reasoning, the logic, the strength of the law.

And reading this opinion today — sometimes I’ll read an opinion and go, Oh, this is weak, or I see what the counter is to this. This opinion is meticulous, it’s airtight. This judge, Judge Pryor and the others on the panel, they go through and systematically address and dissect Mark Meadows’ arguments. And you could almost just global search and replace Meadows for Trump here.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Interventional Ophthalmology: Early Eye Care Strategies Evolve

Updated Category News Views 0

Proactive Eye Care: The New Frontier Today's eye care landscape is all about catching things early, folks. Long gone are the days of waiting for eyesight to deteriorate before rushing to the nearest eye doc. In Racine, interventional ophthalmology is shifting gears towards preventive care—looking ahead to stop eye diseases in their tracks before they muck up a person's...

Continue Reading
Park Systems Expands in the Pacific Northwest

Updated Category News Views 6

Strategic Move into Hillsboro Sparks Industry Buzz Park Systems, already a heavyweight in the nanometrology arena, just made a bold play with the opening of its latest regional office. Nestled in the tech-centric town of Hillsboro, Oregon, this hub is set to redefine how they handle technical support and customer management across the Pacific Northwest. It's like they're...

Continue Reading
Supernova SPAC Lawsuit: Settlement Proposed, $3M on Table

Updated Category News Views 2

Legal Clouds Over Supernova's SPAC Adventure Alright, folks, buckle up, because whenever you mix SPACs and lawsuits, you're in for a roller coaster. Supernova Partners Acquisition Company, Inc. stands right at the heart of a class action lawsuit, and it's been cooking ever since the court in Delaware gave it a nudge forward. Settlement Talk: What's on the Table? So here's...

Continue Reading
Summit Tackles BRI Infrastructure's Role in Global SDGs

Updated Category News Views 3

A Bold Gathering with Lofty Goals Ever watch a room of world leaders debate the finer nuances of sustainable infrastructure? That's something Singapore pulled off on September 6, 2026, with the Second Global Business Summit on Belt and Road Infrastructure Investment. These aren't just any ordinary suits sitting around in a conference room. We're talking about a dynamic...

Continue Reading
Thermoplastic Polyimide: A $0.86 Billion Market by 2032

Updated Category News Views 0

It's not often you get hyped about a compound with a name like 'thermoplastic polyimide,' but hold your horses—this isn't just any chemical. If you're watching markets with a sharp eye, you’ll see this thing estimated at $0.56 billion in 2026, gunning for a hefty $0.86 billion by 2032. We're talking about a solid 7.4% CAGR ride here folks, according to new data from...

Continue Reading
TECNO CAMON Slim 5G: Where Art Meets Tech

Updated Category News Views 1

Unveiling the TECNO CAMON Slim 5G Okay, so imagine a tech brand saying, 'Why not make a phone that’s as much an art piece as it is a gadget?' TECNO just pulled this off with their latest CAMON Slim 5G. The thing's a sleek marvel measuring in at just 6.39mm. Seems like they took a fat-free diet approach to phone design, and not on the digital calories either. A Slim Body...

Continue Reading
Smart City Expo 2026: Innovations in Urban Living

Updated Category News Views 2

Peeling Back the Layers at Smart City Expo 2026 If you can't feel the pulse of change in urban landscapes, you're about to miss the bus. November's Smart City Expo World Congress (SCEWC) is the stage where cities showcase their flashy new upgrades—not just to look sleek but to make tangible, far-reaching impacts. From November 3 to 5, the city's Gran Via venue will host...

Continue Reading
Regeneron Faces Class Action Over Tumultuous Trial Results

Updated Category News Views 0

Regeneron's Meltdown: A Bitter Pill for Investors Let’s dive headlong into the mess Regeneron Pharmaceuticals (NASDAQ:REGN) finds itself in—a classic nightmare scenario for investors. News broke like an old valve bursting, and suddenly, the market's love for Regeneron ran ice-cold. Who's to blame this time? Well, you might want to point a finger at the failed Phase 3...

Continue Reading
Ping An Climbs Sustainability Ladder, Scores A+ Rating

Updated Category News Views 4

Sustainability Triumph for Ping An: A+ Upgrade Ping An Insurance (Group) Company of China, Ltd. is having quite the moment, snagging an A+ in the latest 2026 Sustainability Rating from Hang Seng Indexes Company. This ain't just a one-time pat on the back—it's the third year of consecutive improvement. Looks like Ping An's focus on ESG efforts is finally getting the...

Continue Reading
Nuix Leverages AI for Transformative Legal Review

Updated Category News Views 1

Nuix Unveils AI Innovations in Legal Review Diving headfirst into the evolving world of legal technology, Nuix has just rolled out some serious upgrades to its eDiscovery toolkit. By plucking AI right out of the data science ethers, they're not just dabbling in futuristic tech—they're planting generative AI at the heart of legal review on their SaaS platform, Nuix...

Continue Reading

Top 5 Most Recently Viewed Articles

AlphaSense Drives Healthcare Innovation with AI Insights

Updated Category News Views 694

AlphaSense Enhances Healthcare Industry Insights The company strengthens its dominance in the industry as the focus shifts to innovation and market trends. As healthcare reaches a pivotal point of transformation, AlphaSense is leading the way with unmatched AI-driven market intelligence. With its advanced search capabilities over a vast trove of high-quality business...

Continue Reading
Intchains Group Limited's ETH Strategy and Financial Update

Updated Category News Views 130

Intchains Group Limited: A Look Into Their Latest Financial Results As a noteworthy player in the cryptocurrency landscape, Intchains Group Limited (NASDAQ: ICG) recently shared intriguing insights on its financial performance and operational strategies focused on Ethereum (ETH) as of June 30, 2025. This update serves to highlight their advancements in ETH holdings and...

Continue Reading
Krystal Biotech Sets Stage for Stifel 2024 Conference Insights

Updated Category News Views 181

Krystal Biotech to Attend Stifel 2024 Healthcare Conference Krystal Biotech, Inc. (NASDAQ: KRYS), a notable player in the biotechnology sector, is gearing up to be a part of the Stifel 2024 Healthcare Conference set to take place shortly. The event is highlighted by prominent presentations, including one from Krish S. Krishnan, the Company’s Chairman and Chief Executive...

Continue Reading
The Growth Journey of Cognex: A 15-Year Investment Insight

Updated Category News Views 151

Understanding the Long-Term Value of Cognex Investments Cognex (NASDAQ: CGNX) has demonstrated remarkable market performance, surpassing the overall market by an impressive 3.2% annually over the past decade and a half. This stellar performance translates to an average annual return of approximately 14.78%. As of now, Cognex holds a market capitalization valued at $9.55...

Continue Reading
Autodesk Inc Reaches New Heights with Stock Performance Surge

Updated Category News Views 63

Autodesk Inc Achieves Milestone Stock Performance Autodesk Inc. (NASDAQ: ADSK) has marked a significant milestone by reaching a 52-week high at $279.64, reflecting an upward trajectory in its stock performance. Known for its innovative solutions in the fields of architecture, engineering, and construction, Autodesk has become a key player in the software industry. Over...

Continue Reading